- Home
- Deerfield Special Situations Fund International Lt
Insider Trading History of Deerfield Special Situations Fund International Lt
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Deerfield Special Situations Fund International Lt since 2006.
The trader's CIK number is 1354397.
At the time of the last reporting, Deerfield Special Situations Fund International Lt was the 10% Owner of Hana Biosciences Inc. (stock ticker symbol HNAB).
Also see all insider trading activities at Hana Biosciences Inc.
Note that in the past
Deerfield Special Situations Fund International LT also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Hi Tech Pharmacal Co Inc (HITK) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | HITK | 0 | $0 | 231,377 | $5,853,125 | 0 | $0 |
Yearly summary of insider trading at Xcyte Therapies Inc (CYCC) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | CYCC | 0 | $0 | 741,487 | $270,562 | 0 | $0 |
Yearly summary of insider trading at Neurometrix, Inc. (NURO) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | NURO | 0 | $0 | 3,175,953 | $2,073,371 | 0 | $0 |
| 2009 | NURO | 2,548,673 | $5,097,346 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Via Pharmaceuticals, Inc. (VIAP) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | VIAP | 0 | $0 | 88,126 | $301,074 | 0 | $0 |
Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ANDS | 0 | $0 | 920,000 | $2,005,600 | 0 | $0 |
Yearly summary of insider trading at Nxstage Medical, Inc. (NXTM) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | NXTM | 0 | $0 | 734,770 | $5,277,563 | 0 | $0 |
Yearly summary of insider trading at Fibrocell Science, Inc. (FCSC) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | FCSC | 0 | $0 | 200,000 | $138,000 | 0 | $0 |
Yearly summary of insider trading at Inspire Pharmaceuticals Inc (ISPH) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ISPH | 1,129,895 | $5,376,901 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Third Wave Technologies Inc /wi (TWTI) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | TWTI | 0 | $0 | 762,400 | $4,321,282 | 0 | $0 |
Yearly summary of insider trading at Emageon Inc (EMAGEON IN) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | EMAGEON IN | 0 | $0 | 614,000 | $1,074,500 | 0 | $0 |
Yearly summary of insider trading at Rigel Pharmaceuticals Inc (RIGL) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | RIGL | 0 | $0 | 23,133 | $174,654 | 0 | $0 |
Yearly summary of insider trading at Dusa Pharmaceuticals Inc (DUSA) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | DUSA | 0 | $0 | 1,130,965 | $5,058,223 | 0 | $0 |
| 2009 | DUSA | 673,000 | $683,200 | 29,848 | $31,939 | 0 | $0 |
Yearly summary of insider trading at Par Pharmaceutical Companies, Inc. (PRX) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | PRX | 0 | $0 | 632,047 | $16,982,354 | 0 | $0 |
Yearly summary of insider trading at Ista Pharmaceuticals Inc (ISTA) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ISTA | 697,065 | $3,966,154 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nitromed Inc (NTMD) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | NTMD | 46,085,133 | $39,541,044 | 0 | $0 | 0 | $0 |
| 2008 | NTMD | 903,105 | $990,186 | 460,831 | $248,848 | 0 | $0 |
Yearly summary of insider trading at Dynavax Technologies Corp (DVAX) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | DVAX | 1,659,148 | $8,273,256 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Hana Biosciences Inc (TLON.OB) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | TLON.OB | 0 | $0 | 27,293,530 | $1,528,437 | 0 | $0 |
| 2012 | TLON.OB | 0 | $0 | 2,627,593 | $3,051,850 | 0 | $0 |
| 2011 | TLON.OB | 0 | $0 | 1,426,098 | $1,473,593 | 0 | $0 |
Yearly summary of insider trading at Neurogesx Inc (NGSX) by Deerfield Special Situations Fund International Lt
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | NGSX | 0 | $0 | 686,936 | $4,084,572 | 0 | $0 |
Insider trading activities at 18 companies by Deerfield Special Situations Fund International Lt:
1. Hi Tech Pharmacal Co Inc (HITK)
2. Xcyte Therapies Inc (CYCC)
3. Neurometrix, Inc. (NURO)
4. Via Pharmaceuticals, Inc. (VIAP)
5. Anadys Pharmaceuticals Inc (ANDS)
6. Nxstage Medical, Inc. (NXTM)
7. Fibrocell Science, Inc. (FCSC)
8. Inspire Pharmaceuticals Inc (ISPH)
9. Third Wave Technologies Inc /wi (TWTI)
10. Emageon Inc (EMAGEON IN)
11. Rigel Pharmaceuticals Inc (RIGL)
12. Dusa Pharmaceuticals Inc (DUSA)
13. Par Pharmaceutical Companies, Inc. (PRX)
14. Ista Pharmaceuticals Inc (ISTA)
15. Nitromed Inc (NTMD)
16. Dynavax Technologies Corp (DVAX)
17. Hana Biosciences Inc (TLON.OB)
18. Neurogesx Inc (NGSX)
Table 1. Insider trading of Hi Tech Pharmacal Co Inc (HITK) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-12-09 | HITK | Sale | 1,200 | 26.00 | 31,200 |
| 2010-12-10 | HITK | Sale | 95,177 | 25.00 | 2,379,425 |
| 2010-12-13 | HITK | Sale | 135,000 | 25.50 | 3,442,500 |
Table 2. Insider trading of Xcyte Therapies Inc (CYCC) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-18 | CYCC | Sale | 54,464 | .50 | 27,232 |
| 2008-11-19 | CYCC | Sale | 388,793 | .25 | 97,198 |
| 2008-11-13 | CYCC | Sale | 261,930 | .49 | 128,345 |
| 2008-11-14 | CYCC | Sale | 36,300 | .49 | 17,787 |
Table 3. Insider trading of Neurometrix, Inc. (NURO) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-12-14 | NURO | Sale | 331,900 | .51 | 168,273 |
| 2010-11-18 | NURO | Sale | 623,926 | .58 | 361,877 |
| 2010-11-17 | NURO | Sale | 216,839 | .55 | 118,610 |
| 2010-11-16 | NURO | Sale | 61,882 | .58 | 36,077 |
| 2010-10-26 | NURO | Sale | 99,000 | .59 | 58,410 |
| 2010-09-27 | NURO | Sale | 200 | .58 | 115 |
| 2010-09-24 | NURO | Sale | 20,000 | .58 | 11,600 |
| 2010-09-21 | NURO | Sale | 51,570 | .58 | 30,168 |
| 2010-09-22 | NURO | Sale | 2 | .58 | 1 |
| 2010-09-23 | NURO | Sale | 2,247 | .59 | 1,325 |
| 2010-09-15 | NURO | Sale | 62,500 | .60 | 37,500 |
| 2010-09-16 | NURO | Sale | 700,000 | .58 | 409,500 |
| 2010-08-19 | NURO | Sale | 1,005,887 | .83 | 839,915 |
| 2009-09-09 | NURO | Buy | 2,548,673 | 2.00 | 5,097,346 |
Table 4. Insider trading of Via Pharmaceuticals, Inc. (VIAP) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-11-06 | VIAP | Sale | 63,138 | 3.21 | 202,672 |
| 2007-11-05 | VIAP | Sale | 100 | 3.38 | 337 |
| 2007-10-31 | VIAP | Sale | 116 | 3.96 | 459 |
| 2007-10-26 | VIAP | Sale | 2,307 | 3.92 | 9,050 |
| 2007-10-22 | VIAP | Sale | 704 | 3.98 | 2,801 |
| 2007-10-23 | VIAP | Sale | 100 | 3.96 | 396 |
| 2007-10-24 | VIAP | Sale | 13,167 | 3.91 | 51,535 |
| 2007-10-25 | VIAP | Sale | 2,149 | 3.88 | 8,329 |
| 2007-10-18 | VIAP | Sale | 920 | 3.98 | 3,660 |
| 2007-10-17 | VIAP | Sale | 5,425 | 4.03 | 21,835 |
Table 5. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-18 | ANDS | Sale | 460,000 | 2.18 | 1,002,800 |
| 2008-10-18 | ANDS | Sale | 460,000 | 2.18 | 1,002,800 |
Table 6. Insider trading of Nxstage Medical, Inc. (NXTM) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-12-11 | NXTM | Sale | 10,288 | 12.73 | 131,017 |
| 2009-12-15 | NXTM | Sale | 92,100 | 7.67 | 706,683 |
| 2009-12-09 | NXTM | Sale | 4,311 | 7.36 | 31,728 |
| 2009-12-10 | NXTM | Sale | 17,786 | 7.37 | 131,082 |
| 2009-12-08 | NXTM | Sale | 32,449 | 7.37 | 239,149 |
| 2009-12-07 | NXTM | Sale | 29,163 | 7.37 | 214,931 |
| 2009-12-04 | NXTM | Sale | 20,665 | 7.37 | 152,301 |
| 2009-12-03 | NXTM | Sale | 156,400 | 7.44 | 1,163,616 |
| 2009-10-09 | NXTM | Sale | 11,602 | 6.74 | 78,139 |
| 2009-09-29 | NXTM | Sale | 3,669 | 7.07 | 25,939 |
| 2009-09-21 | NXTM | Sale | 993 | 6.72 | 6,672 |
| 2009-09-23 | NXTM | Sale | 33,168 | 6.74 | 223,552 |
| 2009-09-17 | NXTM | Sale | 30,869 | 6.74 | 208,057 |
| 2009-09-18 | NXTM | Sale | 37,591 | 6.73 | 252,987 |
| 2009-09-15 | NXTM | Sale | 30,805 | 6.72 | 207,009 |
| 2009-09-14 | NXTM | Sale | 64,060 | 6.74 | 431,764 |
| 2009-09-11 | NXTM | Sale | 103,148 | 6.97 | 719,251 |
| 2009-09-16 | NXTM | Sale | 28,625 | 6.72 | 192,302 |
| 2009-06-12 | NXTM | Sale | 27,078 | 5.96 | 161,384 |
Table 7. Insider trading of Fibrocell Science, Inc. (FCSC) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-08-16 | FCSC | Sale | 200,000 | .69 | 138,000 |
Table 8. Insider trading of Inspire Pharmaceuticals Inc (ISPH) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-10 | ISPH | Buy | 133,000 | 4.84 | 643,853 |
| 2006-05-09 | ISPH | Buy | 67,000 | 4.87 | 326,089 |
| 2006-05-02 | ISPH | Buy | 74,410 | 4.85 | 360,888 |
| 2006-04-11 | ISPH | Buy | 100,000 | 4.85 | 484,999 |
| 2006-03-28 | ISPH | Buy | 2,675 | 4.78 | 12,786 |
| 2006-03-07 | ISPH | Buy | 82,200 | 4.95 | 406,479 |
| 2006-02-22 | ISPH | Buy | 670,610 | 4.68 | 3,141,807 |
Table 9. Insider trading of Third Wave Technologies Inc /wi (TWTI) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-21 | TWTI | Sale | 327,554 | 5.45 | 1,785,496 |
| 2007-04-26 | TWTI | Sale | 3,570 | 5.73 | 20,470 |
| 2007-04-27 | TWTI | Sale | 61,341 | 5.66 | 347,435 |
| 2007-04-25 | TWTI | Sale | 4,500 | 5.72 | 25,740 |
| 2007-04-24 | TWTI | Sale | 27,714 | 5.75 | 159,355 |
| 2007-04-23 | TWTI | Sale | 36,171 | 5.77 | 208,815 |
| 2007-04-20 | TWTI | Sale | 22,800 | 5.75 | 131,214 |
| 2007-04-17 | TWTI | Sale | 250,000 | 5.90 | 1,475,000 |
| 2007-04-18 | TWTI | Sale | 5,700 | 5.90 | 33,630 |
| 2007-04-19 | TWTI | Sale | 23,050 | 5.82 | 134,127 |
Table 10. Insider trading of Emageon Inc (EMAGEON IN) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-02-26 | EMAGEON IN | Sale | 614,000 | 1.75 | 1,074,500 |
Table 11. Insider trading of Rigel Pharmaceuticals Inc (RIGL) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-11-03 | RIGL | Sale | 7,711 | 7.55 | 58,218 |
| 2010-11-03 | RIGL | Sale | 7,711 | 7.55 | 58,218 |
| 2010-11-03 | RIGL | Sale | 7,711 | 7.55 | 58,218 |
Table 12. Insider trading of Dusa Pharmaceuticals Inc (DUSA) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-03-18 | DUSA | Sale | 3,200 | 4.61 | 14,752 |
| 2011-03-22 | DUSA | Sale | 94,000 | 4.34 | 408,242 |
| 2011-03-21 | DUSA | Sale | 93,224 | 4.57 | 425,567 |
| 2011-03-15 | DUSA | Sale | 425,000 | 4.34 | 1,843,225 |
| 2011-03-16 | DUSA | Sale | 68,430 | 4.58 | 313,751 |
| 2011-03-17 | DUSA | Sale | 447,111 | 4.59 | 2,052,686 |
| 2009-06-25 | DUSA | Buy | 423,000 | .90 | 380,700 |
| 2009-03-11 | DUSA | Buy | 250,000 | 1.21 | 302,500 |
| 2009-02-23 | DUSA | Sale | 29,648 | 1.07 | 31,723 |
| 2009-02-24 | DUSA | Sale | 200 | 1.08 | 216 |
Table 13. Insider trading of Par Pharmaceutical Companies, Inc. (PRX) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-02-01 | PRX | Sale | 465,000 | 26.90 | 12,510,360 |
| 2007-01-30 | PRX | Sale | 74,542 | 27.08 | 2,018,299 |
| 2007-01-31 | PRX | Sale | 92,505 | 26.52 | 2,453,695 |
Table 14. Insider trading of Ista Pharmaceuticals Inc (ISTA) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-06-01 | ISTA | Buy | 812 | 5.63 | 4,573 |
| 2006-05-30 | ISTA | Buy | 76,051 | 5.77 | 438,814 |
| 2006-05-24 | ISTA | Buy | 17,828 | 5.59 | 99,712 |
| 2006-05-25 | ISTA | Buy | 4,700 | 5.73 | 26,926 |
| 2006-05-22 | ISTA | Buy | 1,222 | 5.75 | 7,022 |
| 2006-05-23 | ISTA | Buy | 102,040 | 5.58 | 569,383 |
| 2006-05-19 | ISTA | Buy | 102,632 | 5.69 | 584,283 |
| 2006-05-18 | ISTA | Buy | 50,268 | 5.65 | 284,165 |
| 2006-05-19 | ISTA | Buy | 102,632 | 5.69 | 584,283 |
| 2006-05-18 | ISTA | Buy | 50,268 | 5.65 | 284,165 |
| 2006-05-16 | ISTA | Buy | 30,300 | 5.71 | 172,861 |
| 2006-05-15 | ISTA | Buy | 9,595 | 5.75 | 55,132 |
| 2006-05-12 | ISTA | Buy | 10,350 | 5.74 | 59,398 |
| 2006-05-11 | ISTA | Buy | 56,539 | 5.75 | 324,873 |
| 2006-04-21 | ISTA | Buy | 21,000 | 5.87 | 123,228 |
| 2006-04-19 | ISTA | Buy | 13,900 | 5.90 | 82,010 |
| 2006-04-18 | ISTA | Buy | 8,453 | 5.78 | 48,866 |
| 2006-05-10 | ISTA | Buy | 38,475 | 5.63 | 216,460 |
Table 15. Insider trading of Nitromed Inc (NTMD) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-24 | NTMD | Buy | 46,085,133 | .86 | 39,541,044 |
| 2008-12-23 | NTMD | Sale | 460,831 | .54 | 248,848 |
| 2008-08-04 | NTMD | Buy | 2,035 | 1.01 | 2,055 |
| 2008-07-31 | NTMD | Buy | 3,688 | 1.01 | 3,724 |
| 2008-07-29 | NTMD | Buy | 6,762 | 1.01 | 6,829 |
| 2008-07-30 | NTMD | Buy | 11,000 | 1.01 | 11,110 |
| 2008-07-28 | NTMD | Buy | 50,140 | 1.00 | 50,140 |
| 2008-07-29 | NTMD | Buy | 980 | 1.01 | 988 |
| 2008-07-23 | NTMD | Buy | 11,952 | 1.02 | 12,191 |
| 2008-07-24 | NTMD | Buy | 19,900 | 1.00 | 19,900 |
| 2008-07-25 | NTMD | Buy | 8,950 | 1.02 | 9,173 |
| 2008-07-18 | NTMD | Buy | 43,619 | 1.02 | 44,491 |
| 2008-07-21 | NTMD | Buy | 59,117 | 1.01 | 59,708 |
| 2008-07-15 | NTMD | Buy | 420 | 1.01 | 424 |
| 2008-07-16 | NTMD | Buy | 1,190 | .99 | 1,178 |
| 2008-07-10 | NTMD | Buy | 19,134 | .98 | 18,751 |
| 2008-07-11 | NTMD | Buy | 24,188 | .97 | 23,462 |
| 2008-07-14 | NTMD | Buy | 24,940 | 1.02 | 25,438 |
| 2008-07-09 | NTMD | Buy | 34,096 | .95 | 32,391 |
| 2008-07-08 | NTMD | Buy | 8,970 | 1.00 | 8,961 |
| 2008-07-01 | NTMD | Buy | 300 | 1.01 | 303 |
| 2008-07-07 | NTMD | Buy | 36,520 | .98 | 35,789 |
| 2008-06-26 | NTMD | Buy | 3,318 | 1.03 | 3,417 |
| 2008-06-27 | NTMD | Buy | 41,895 | 1.03 | 43,151 |
| 2008-06-30 | NTMD | Buy | 39,475 | .98 | 38,685 |
| 2008-05-19 | NTMD | Buy | 18,182 | 1.15 | 20,909 |
| 2008-05-16 | NTMD | Buy | 66,479 | 1.15 | 76,450 |
| 2008-05-15 | NTMD | Buy | 22,880 | 1.15 | 26,311 |
| 2008-05-12 | NTMD | Buy | 17,465 | 1.14 | 19,910 |
| 2008-05-13 | NTMD | Buy | 13,699 | 1.12 | 15,342 |
| 2008-05-14 | NTMD | Buy | 25,282 | 1.16 | 29,327 |
| 2008-05-09 | NTMD | Buy | 53,009 | 1.12 | 59,370 |
| 2008-05-08 | NTMD | Buy | 26,300 | 1.17 | 30,770 |
| 2008-05-07 | NTMD | Buy | 45,149 | 1.21 | 54,630 |
| 2008-05-05 | NTMD | Buy | 69,964 | 1.27 | 88,854 |
| 2008-05-06 | NTMD | Buy | 75,507 | 1.26 | 95,138 |
| 2008-05-02 | NTMD | Buy | 16,600 | 1.26 | 20,916 |
Table 16. Insider trading of Dynavax Technologies Corp (DVAX) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-10-04 | DVAX | Buy | 950,000 | 4.40 | 4,180,000 |
| 2006-05-15 | DVAX | Buy | 87,665 | 5.50 | 482,069 |
| 2006-05-12 | DVAX | Buy | 10,246 | 5.50 | 56,342 |
| 2006-05-11 | DVAX | Buy | 4,828 | 5.12 | 24,695 |
| 2006-05-01 | DVAX | Buy | 11,400 | 5.71 | 65,082 |
| 2006-04-28 | DVAX | Buy | 57,800 | 5.61 | 324,084 |
| 2006-04-24 | DVAX | Buy | 72,245 | 5.55 | 400,959 |
| 2006-04-20 | DVAX | Buy | 29,840 | 5.48 | 163,463 |
| 2006-04-21 | DVAX | Buy | 40,000 | 5.43 | 217,320 |
| 2006-04-05 | DVAX | Buy | 25,276 | 6.02 | 152,060 |
| 2006-04-04 | DVAX | Buy | 49,109 | 6.03 | 296,323 |
| 2006-04-03 | DVAX | Buy | 48,100 | 6.03 | 290,091 |
| 2006-03-16 | DVAX | Buy | 37,934 | 6.02 | 228,438 |
| 2006-03-17 | DVAX | Buy | 14,484 | 5.91 | 85,585 |
| 2006-03-15 | DVAX | Buy | 68,191 | 5.95 | 405,941 |
| 2006-03-07 | DVAX | Buy | 17,500 | 6.00 | 105,000 |
| 2006-03-09 | DVAX | Buy | 15,300 | 6.03 | 92,228 |
| 2006-03-03 | DVAX | Buy | 119,230 | 5.90 | 703,576 |
Table 17. Insider trading of Hana Biosciences Inc (TLON.OB) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-16 | TLON.OB | Sale | 27,293,530 | .06 | 1,528,437 |
| 2012-07-05 | TLON.OB | Sale | 540,000 | 1.22 | 658,800 |
| 2012-06-29 | TLON.OB | Sale | 194,635 | 1.14 | 221,883 |
| 2012-07-02 | TLON.OB | Sale | 166,527 | 1.20 | 199,832 |
| 2012-07-03 | TLON.OB | Sale | 550,752 | 1.33 | 732,500 |
| 2012-06-27 | TLON.OB | Sale | 116,256 | 1.00 | 116,256 |
| 2012-06-26 | TLON.OB | Sale | 62,317 | .98 | 61,070 |
| 2012-06-28 | TLON.OB | Sale | 219,800 | 1.07 | 235,186 |
| 2012-05-03 | TLON.OB | Sale | 231,100 | .98 | 227,633 |
| 2012-03-21 | TLON.OB | Sale | 115,000 | 1.05 | 120,750 |
| 2012-03-14 | TLON.OB | Sale | 35,526 | 1.01 | 35,881 |
| 2012-03-12 | TLON.OB | Sale | 123,180 | 1.11 | 136,729 |
| 2012-03-13 | TLON.OB | Sale | 18,500 | 1.04 | 19,240 |
| 2012-03-09 | TLON.OB | Sale | 153,000 | 1.20 | 183,600 |
| 2012-03-08 | TLON.OB | Sale | 55,000 | 1.04 | 57,200 |
| 2012-03-07 | TLON.OB | Sale | 21,000 | .99 | 20,790 |
| 2012-02-06 | TLON.OB | Sale | 25,000 | .98 | 24,500 |
| 2011-09-26 | TLON.OB | Sale | 7,500 | 1.00 | 7,500 |
| 2011-09-22 | TLON.OB | Sale | 11,493 | .98 | 11,263 |
| 2011-09-20 | TLON.OB | Sale | 25,499 | 1.00 | 25,499 |
| 2011-09-19 | TLON.OB | Sale | 33,000 | 1.05 | 34,650 |
| 2011-08-31 | TLON.OB | Sale | 85,500 | .97 | 82,935 |
| 2011-07-14 | TLON.OB | Sale | 13,200 | .99 | 13,068 |
| 2011-06-24 | TLON.OB | Sale | 88,793 | 1.07 | 95,008 |
| 2011-06-23 | TLON.OB | Sale | 141,207 | 1.03 | 145,019 |
| 2011-06-27 | TLON.OB | Sale | 15,500 | 1.06 | 16,430 |
| 2011-06-13 | TLON.OB | Sale | 33,181 | 1.02 | 33,844 |
| 2011-06-03 | TLON.OB | Sale | 9,130 | 1.01 | 9,221 |
| 2011-06-06 | TLON.OB | Sale | 43,000 | 1.02 | 43,860 |
| 2011-06-07 | TLON.OB | Sale | 55,000 | 1.03 | 56,650 |
| 2011-05-27 | TLON.OB | Sale | 44,700 | .99 | 44,253 |
| 2011-05-26 | TLON.OB | Sale | 121,880 | 1.01 | 123,098 |
| 2011-05-31 | TLON.OB | Sale | 26,292 | .99 | 26,029 |
| 2011-05-20 | TLON.OB | Sale | 76,395 | .99 | 76,013 |
| 2011-05-23 | TLON.OB | Sale | 16,207 | 1.00 | 16,207 |
| 2011-05-24 | TLON.OB | Sale | 281,001 | 1.00 | 281,001 |
| 2011-05-17 | TLON.OB | Sale | 168,822 | 1.12 | 189,080 |
| 2011-05-18 | TLON.OB | Sale | 76,759 | 1.11 | 85,202 |
| 2011-05-19 | TLON.OB | Sale | 52,039 | 1.11 | 57,763 |
Table 18. Insider trading of Neurogesx Inc (NGSX) by Deerfield Special Situations Fund International Lt
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-07-13 | NGSX | Sale | 250,152 | 5.97 | 1,493,407 |
| 2009-07-08 | NGSX | Sale | 13,694 | 5.89 | 80,657 |
| 2009-07-09 | NGSX | Sale | 10,000 | 5.97 | 59,700 |
| 2009-07-07 | NGSX | Sale | 29,851 | 5.96 | 177,911 |
| 2009-07-06 | NGSX | Sale | 24,599 | 5.90 | 145,134 |
| 2009-06-26 | NGSX | Sale | 259,549 | 5.86 | 1,520,957 |
| 2009-06-30 | NGSX | Sale | 15,764 | 5.99 | 94,426 |
| 2009-06-22 | NGSX | Sale | 35,783 | 6.33 | 226,685 |
| 2009-06-23 | NGSX | Sale | 35,887 | 6.08 | 218,085 |
| 2009-06-24 | NGSX | Sale | 11,657 | 5.80 | 67,610 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Deerfield Special Situations Fund International Lt
(10% Owner of Hana Biosciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.